H1N1 pneumonitis treated with intravenous zanamivir

Lancet. 2009 Sep 19;374(9694):1036. doi: 10.1016/S0140-6736(09)61528-2. Epub 2009 Sep 3.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Bronchoalveolar Lavage Fluid / virology
  • Critical Care / methods
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Hodgkin Disease / drug therapy
  • Humans
  • Immunocompromised Host*
  • Influenza A Virus, H1N1 Subtype*
  • Infusions, Intravenous
  • Methylprednisolone / therapeutic use
  • Neutropenia / chemically induced
  • Neutropenia / complications
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / virology
  • Treatment Outcome
  • Viral Load
  • Zanamivir / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Zanamivir
  • Methylprednisolone